Profile
Ludovic Robin served as Deputy Chief Executive Officer at Advicenne SA. He worked at Shire Plc as Marketing Director & Head-Commercial Operations from 2008 to 2016.
Robin also served as Chief Business Officer at PCI Biotech Holding ASA from 2020 to 2022.
He holds an MBA from École des Hautes Études Commerciales de Paris, a doctorate from the University of Lyon, and a graduate degree from Institut de Pharmacie Industrielle de Lyon.
Former positions of Ludovic Robin
| Companies | Position | End |
|---|---|---|
| PCI BIOTECH HOLDING ASA | Corporate Officer/Principal | 2022-04-30 |
| SHIRE | Corporate Officer/Principal | - |
| ADVICENNE | Corporate Officer/Principal | - |
Training of Ludovic Robin
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
| University of Lyon | Doctorate Degree |
| Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PCI BIOTECH HOLDING ASA | Health Technology |
| ADVICENNE | Health Technology |
| Private companies | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Ludovic Robin
